• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶抑制剂和 IL21 共同重编程人效应性 CD8 T 细胞为记忆 T 细胞。

Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8 T Cells to Memory T Cells.

机构信息

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas.

出版信息

Cancer Immunol Res. 2020 Jun;8(6):794-805. doi: 10.1158/2326-6066.CIR-19-0619. Epub 2020 Mar 25.

DOI:10.1158/2326-6066.CIR-19-0619
PMID:32213626
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7269845/
Abstract

Clinical response rates after adoptive cell therapy (ACT) are highly correlated with persistence of the infused T cells. However, antigen-specific T cells found in tumor sites are often well-differentiated effector cells with limited persistence. Central memory CD8 T cells, capable of self-renewal, represent desirable ACT products. We report here that exposure to a histone deacetylase inhibitor (HDACi) and IL21 could reprogram differentiated human CD8 T cells into central memory-like T cells. Dedifferentiation of CD8 T cells was initiated by increased H3 acetylation and chromatin accessibility at the promoter region. This led to IL21-mediated pSTAT3 binding to the region, and subsequent upregulation of surface CD28 and CD62L (markers of central memory T cells). The reprogrammed cells exhibited enhanced proliferation in response to both IL2 and IL15, and a stable memory-associated transcriptional signature (increased and ). Our findings support the application of IL21 and HDACi for the generation of highly persistent T-cell populations that can augment the efficacy of adoptively transferred T cells.

摘要

过继细胞疗法 (ACT) 后的临床反应率与输注 T 细胞的持久性高度相关。然而,肿瘤部位存在的抗原特异性 T 细胞通常是分化良好的效应细胞,其持久性有限。具有自我更新能力的中央记忆 CD8 T 细胞是理想的 ACT 产品。我们在这里报告,暴露于组蛋白去乙酰化酶抑制剂 (HDACi) 和 IL21 可以将分化的人 CD8 T 细胞重新编程为中央记忆样 T 细胞。CD8 T 细胞的去分化是由启动子区域 H3 乙酰化和染色质可及性增加引发的。这导致 IL21 介导的 pSTAT3 与 区域结合,随后上调表面 CD28 和 CD62L(中央记忆 T 细胞的标志物)。重编程细胞对 IL2 和 IL15 的反应均增强了增殖能力,并且具有稳定的记忆相关转录特征(增加 和 )。我们的研究结果支持应用 IL21 和 HDACi 来产生高度持久的 T 细胞群体,从而增强过继转移 T 细胞的疗效。

相似文献

1
Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8 T Cells to Memory T Cells.组蛋白去乙酰化酶抑制剂和 IL21 共同重编程人效应性 CD8 T 细胞为记忆 T 细胞。
Cancer Immunol Res. 2020 Jun;8(6):794-805. doi: 10.1158/2326-6066.CIR-19-0619. Epub 2020 Mar 25.
2
A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.短时间的CD3/CD28共刺激联合IL-21可增强用于过继性免疫治疗的人记忆性干细胞T细胞的生成。
J Transl Med. 2016 Jul 19;14(1):214. doi: 10.1186/s12967-016-0973-y.
3
Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.基于记忆T细胞的过继性免疫疗法在小鼠中增强局部和全身抗黑色素瘤CD8 + T细胞反应。
Cancer Immunol Immunother. 2016 May;65(5):601-11. doi: 10.1007/s00262-016-1823-8. Epub 2016 Mar 24.
4
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy.4-1BB/CD137 共刺激可改善过继性 T 细胞治疗中 CD8(+)黑色素瘤肿瘤浸润淋巴细胞的扩增和功能。
PLoS One. 2013;8(4):e60031. doi: 10.1371/journal.pone.0060031. Epub 2013 Apr 1.
5
Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy.过继性细胞转移治疗后人类晚期效应T细胞向CD27+CD28+肿瘤反应性效应记忆T细胞的转变。
Blood. 2005 Jan 1;105(1):241-50. doi: 10.1182/blood-2004-06-2482. Epub 2004 Sep 2.
6
4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.在为过继性免疫治疗产生CD8 + 细胞毒性淋巴细胞方面,4-1BB优于CD28共刺激。
J Immunol. 2007 Oct 1;179(7):4910-8. doi: 10.4049/jimmunol.179.7.4910.
7
Interrupting CD28 costimulation before antigen rechallenge affects CD8(+) T-cell expansion and effector functions during secondary response in mice.在抗原再次刺激前阻断CD28共刺激会影响小鼠二次应答期间CD8(+) T细胞的扩增和效应功能。
Eur J Immunol. 2016 Jul;46(7):1644-55. doi: 10.1002/eji.201546232. Epub 2016 May 17.
8
Phenotypic and functional attributes of lentivirus-modified CD19-specific human CD8+ central memory T cells manufactured at clinical scale.临床级制备的慢病毒修饰的 CD19 特异性人 CD8+ 中央记忆 T 细胞的表型和功能特征。
J Immunother. 2012 Nov-Dec;35(9):689-701. doi: 10.1097/CJI.0b013e318270dec7.
9
Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice.人源中枢记忆效应性 CD8+ T 细胞在免疫缺陷小鼠中的植入。
Blood. 2011 Feb 10;117(6):1888-98. doi: 10.1182/blood-2010-10-310599. Epub 2010 Dec 1.
10
IL-21 preferentially enhances IL-15-mediated homeostatic proliferation of human CD28+ CD8 memory T cells throughout the adult age span.IL-21 优先增强了人类 CD28+CD8+记忆 T 细胞中 IL-15 介导的稳态增殖,贯穿整个成年期。
J Leukoc Biol. 2010 Jan;87(1):43-9. doi: 10.1189/jlb.0209086. Epub 2009 Oct 1.

引用本文的文献

1
Interleukin 21-Armed EGFR-VHH-CAR-T Cell Therapy for the Treatment of Esophageal Squamous Cell Carcinoma.白细胞介素21武装的表皮生长因子受体VHH嵌合抗原受体T细胞疗法治疗食管鳞状细胞癌
Biomedicines. 2025 Jun 30;13(7):1598. doi: 10.3390/biomedicines13071598.
2
BH3 mimetics augment cytotoxic T cell killing of acute myeloid leukemia via mitochondrial apoptotic mechanism.BH3模拟物通过线粒体凋亡机制增强细胞毒性T细胞对急性髓系白血病的杀伤作用。
Cell Death Discov. 2025 Mar 26;11(1):120. doi: 10.1038/s41420-025-02375-2.
3
Dysfunction and regulatory interplay of T and B cells in chronic hepatitis B: immunotherapy and emerging antiviral strategies.

本文引用的文献

1
RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types.RNA-Seq 特征通过 mRNA 丰度标准化可实现人类免疫细胞类型的绝对分解。
Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041.
2
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy.抑制 AKT 信号通路可将受体工程化过继免疫疗法中的 T 细胞分化与扩增脱耦联。
JCI Insight. 2017 Dec 7;2(23):95103. doi: 10.1172/jci.insight.95103.
3
Multifaceted Role of BTLA in the Control of CD8 T-cell Fate after Antigen Encounter.
慢性乙型肝炎中T细胞和B细胞的功能障碍及调节相互作用:免疫疗法与新兴抗病毒策略
Front Cell Infect Microbiol. 2024 Dec 9;14:1488527. doi: 10.3389/fcimb.2024.1488527. eCollection 2024.
4
BH3 Mimetics Augment Cytotoxic T Cell Killing of Acute Myeloid Leukemia via Mitochondrial Apoptotic Mechanism.BH3模拟物通过线粒体凋亡机制增强细胞毒性T细胞对急性髓系白血病的杀伤作用。
Res Sq. 2024 Dec 9:rs.3.rs-5307127. doi: 10.21203/rs.3.rs-5307127/v1.
5
Low-dose SAHA enhances CD8 T cell-mediated antitumor immunity by boosting MHC I expression in non-small cell lung cancer.低剂量SAHA通过提高非小细胞肺癌中MHC I的表达来增强CD8 T细胞介导的抗肿瘤免疫力。
Cell Oncol (Dordr). 2025 Feb;48(1):249-264. doi: 10.1007/s13402-024-00989-9. Epub 2024 Sep 16.
6
shRNA-mediated gene silencing of HDAC11 empowers CAR-T cells against prostate cancer.shRNA 介导的 HDAC11 基因沉默增强了 CAR-T 细胞对前列腺癌的作用。
Front Immunol. 2024 May 21;15:1369406. doi: 10.3389/fimmu.2024.1369406. eCollection 2024.
7
Advances in targeting histone deacetylase for treatment of solid tumors.靶向组蛋白去乙酰化酶治疗实体瘤的研究进展。
J Hematol Oncol. 2024 May 31;17(1):37. doi: 10.1186/s13045-024-01551-8.
8
SIRT2 inhibition by AGK2 enhances mycobacteria-specific stem cell memory responses by modulating beta-catenin and glycolysis.AGK2对SIRT2的抑制作用通过调节β-连环蛋白和糖酵解增强了分枝杆菌特异性干细胞记忆反应。
iScience. 2023 Apr 10;26(5):106644. doi: 10.1016/j.isci.2023.106644. eCollection 2023 May 19.
9
From immune equilibrium to immunodynamics.从免疫平衡到免疫动力学。
Front Microbiol. 2022 Nov 25;13:1018817. doi: 10.3389/fmicb.2022.1018817. eCollection 2022.
10
Characterization of the effect of histone deacetylation inhibitors on CD8 T cells in the context of aging.在衰老背景下组蛋白去乙酰化酶抑制剂对 CD8 T 细胞的作用特征。
J Transl Med. 2022 Nov 22;20(1):539. doi: 10.1186/s12967-022-03733-9.
BTLA 在抗原识别后控制 CD8 T 细胞命运中的多效性作用。
Clin Cancer Res. 2017 Oct 15;23(20):6151-6164. doi: 10.1158/1078-0432.CCR-16-1217. Epub 2017 Jul 28.
4
SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity.SLC45A2:一种具有高肿瘤选择性和降低自身免疫毒性潜力的黑色素瘤抗原。
Cancer Immunol Res. 2017 Aug;5(8):618-629. doi: 10.1158/2326-6066.CIR-17-0051. Epub 2017 Jun 19.
5
Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors.皮肤T细胞淋巴瘤的染色质可及性图谱及对组蛋白去乙酰化酶抑制剂的动态反应
Cancer Cell. 2017 Jul 10;32(1):27-41.e4. doi: 10.1016/j.ccell.2017.05.008. Epub 2017 Jun 15.
6
Epigenomics of human CD8 T cell differentiation and aging.人类CD8 T细胞分化与衰老的表观基因组学
Sci Immunol. 2017 Feb;2(8). doi: 10.1126/sciimmunol.aag0192. Epub 2017 Feb 17.
7
Tracking the Fate and Origin of Clinically Relevant Adoptively Transferred CD8 T Cells .追踪临床相关过继性转移CD8 T细胞的命运和来源
Sci Immunol. 2017 Feb;2(8). doi: 10.1126/sciimmunol.aal2568. Epub 2017 Feb 24.
8
Epigenetic Networks Regulate the Transcriptional Program in Memory and Terminally Differentiated CD8+ T Cells.表观遗传网络调控记忆性和终末分化CD8+ T细胞中的转录程序。
J Immunol. 2017 Jan 15;198(2):937-949. doi: 10.4049/jimmunol.1601102. Epub 2016 Dec 14.
9
T cell metabolism drives immunity.T细胞代谢驱动免疫。
J Exp Med. 2015 Aug 24;212(9):1345-60. doi: 10.1084/jem.20151159. Epub 2015 Aug 10.
10
Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics.Akt 抑制增强了具有记忆细胞特征的强效肿瘤特异性淋巴细胞的扩增。
Cancer Res. 2015 Jan 15;75(2):296-305. doi: 10.1158/0008-5472.CAN-14-2277. Epub 2014 Nov 28.